Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel-group, Randomized, Prospective, Interventional, Double-blind, Multicenter Global Phase 3 Study to Investigate the Efficacy and Safety of Finerenone Versus Placebo, in Participants With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

NCT07181135 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT07181135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07181135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel-group, Randomized, Prospective, Interventional, Double-blind, Multicenter Global Phase 3 Study to Investigate the Efficacy and Safety of Finerenone Versus Placebo, in Participants With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
Lead sponsor
University Medical Center Groningen
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
March 13, 2026
Completion date
December 31, 2027
Enrollment
180 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease